Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Venex is a medical device company focused on the development and commercialization of innovative treatments for venous diseases, specifically chronic venous insufficiency and varicose veins. The company's flagship product is the Venex Closure System, a minimally invasive solution designed to treat incompetent great saphenous veins through a proprietary mechanical-chemical ablation process. By combining mechanical disruption of the vessel wall with the delivery of a sclerosant, the system aims to provide a more efficient and patient-friendly alternative to traditional thermal ablation techniques. Venex targets the global vascular surgery market, providing tools that simplify procedures for clinicians while improving recovery times for patients.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Venex.